Breakthrough in the Development of a New Foot-and-Mouth Disease Vaccine
INTA, the National Research Council of Canada (NRCC), and Bioinnovo—a technology-based company established jointly by INTA and Vetanco SA—are currently developing the first vaccine against the foot-and-mouth disease virus (FMDV) that completely eliminates the use of infective material in its manufacturing process. This achievement represents…